DalCor Pharmaceuticals
- Website
- dalcorpharma.com
- Total Funding
- $230.0M
- Last Round
- $80.0M Series DSep 2023
- Rounds
- 2
About
DalCor Pharmaceuticals is a Drug Discovery company. It has raised $230.0M in total across 2 rounds, most recently a $80.0M Series D round in Sep 2023. Investors include Sanderling Ventures, Fonds de solidarité FTQ and CTI Life Sciences Fund.
Funding History
Sep 2023
Sign up to see all 2 events
Funding: Venture Round through Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
Verve Therapeutics develops gene-editing treatments for atherosclerotic cardiovascular disease us...
Clinical-stage biotech developing precision medicines for genetically defined Parkinson’s disease...
Precision immunology company using AI and clinico-genomic data to match autoimmune patients with ...
SpliceBio develops next-generation gene therapies using its proprietary Protein Splicing platform...
The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/dalcor-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/dalcor-pharmaceuticals" alt="DalCor Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>